洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2100048866】THE EFFECTS OF COVID-19 PANDEMIC ON EMERGENCY ANTERIOR ABDOMINAL WALL HERNIA SURGERY

基本信息
登记号

ChiCTR2100048866

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2021-07-18

临床申请受理号

/

靶点

/

适应症

新型冠状病毒肺炎(COVID-19)

试验通俗题目

THE EFFECTS OF COVID-19 PANDEMIC ON EMERGENCY ANTERIOR ABDOMINAL WALL HERNIA SURGERY

试验专业题目

THE EFFECTS OF COVID-19 PANDEMIC ON EMERGENCY ANTERIOR ABDOMINAL WALL HERNIA SURGERY: IS IT SAFE TO POSTPONE ELECTIVE HERNIA SURGERY IN THE PANDEMIC?

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

The aim of this study was to investigate the effects of COVID-19 infection on Emergency anteior abdominal wall hernia surgery by comparing the outcomes of patients who underwent during the pandemic with those who underwent the same surgery in the non-pandemic control period a year ago. Furthermore we aimed to share our precautions and experiences during the pandemic.

试验分类
试验类型

析因分组(即根据危险因素或暴露因素分组)

试验分期

回顾性研究

随机化

No

盲法

No

试验项目经费来源

No

试验范围

/

目标入组人数

66

实际入组人数

/

第一例入组时间

2019-03-11

试验终止时间

2021-01-25

是否属于一致性

/

入选标准

All emergent anterior abdominal wall surgeries in control and pandeic periods;

排除标准

Emergency surgeries without primary anterior abdominal wall repair surgery were excluded from the study (For example: Repairing the incisional hernia of a patient who had ileus surgery);

研究者信息
研究负责人姓名
试验机构

Ahmet Baris Dirim

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品

同适应症药物临床试验